These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36129422)

  • 1. Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: COMMENTARY.
    Shirali AC
    Kidney360; 2022 May; 3(5):806-808. PubMed ID: 36129422
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO.
    Herrmann SM
    Kidney360; 2022 May; 3(5):799-802. PubMed ID: 36128487
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: CON.
    Kanduri SR; Velez JCQ
    Kidney360; 2022 May; 3(5):803-805. PubMed ID: 36128485
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
    Gupta S; Cortazar FB; Riella LV; Leaf DE
    Kidney360; 2020 Feb; 1(2):130-140. PubMed ID: 35372904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.
    Rashidi A; Shah C; Sekulic M
    Kidney360; 2022 Mar; 3(3):530-533. PubMed ID: 35582173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
    Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
    Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.
    Perazella MA
    Kidney360; 2020 Mar; 1(3):166-168. PubMed ID: 35378019
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.
    Espi M; Teuma C; Novel-Catin E; Maillet D; Souquet PJ; Dalle S; Koppe L; Fouque D
    Eur J Cancer; 2021 Apr; 147():29-39. PubMed ID: 33607383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria.
    Verploegen MFA; Boers-Sonderen MJ; Piet B; Wetzels JFM
    Kidney360; 2022 Mar; 3(3):524-529. PubMed ID: 35582168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitors and acute kidney injury.
    Zhou P; Gao Y; Kong Z; Wang J; Si S; Han W; Li J; Lv Z; Wang R
    Front Immunol; 2024; 15():1353339. PubMed ID: 38464524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: CON.
    Gutgarts V; Glezerman IG
    Kidney360; 2020 Mar; 1(3):162-165. PubMed ID: 35368625
    [No Abstract]   [Full Text] [Related]  

  • 12. Single and combination immunotherapy with chemotherapy and the risk of AKI in patients with solid cancer.
    de Brito GA; Junior APN; Silva MBE; Bettim BB; Pereira BJ
    Clin Exp Nephrol; 2024 Apr; 28(4):273-281. PubMed ID: 37995062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitor-Associated AKI: Debates in Diagnosis, Management, and Rechallenge.
    Seethapathy H; Herrmann SM; Rashidi A
    Semin Nephrol; 2022 Nov; 42(6):151346. PubMed ID: 37137187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitors-induced nephropathy: a French national survey.
    Gérard AO; Andreani M; Fresse A; Parassol N; Muzzone M; Pinel S; Bourneau-Martin D; Borchiellini D; Rocher F; Esnault VLM; Drici MD;
    Cancer Immunol Immunother; 2021 Nov; 70(11):3357-3364. PubMed ID: 34155532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: PRO.
    Eijgelsheim M; Sprangers B
    Kidney360; 2020 Mar; 1(3):158-161. PubMed ID: 35368633
    [No Abstract]   [Full Text] [Related]  

  • 16. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
    Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E
    Front Immunol; 2020; 11():574271. PubMed ID: 33162990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitor-Associated Nephrotoxicity.
    Mamlouk O; Danesh FR
    Nephron; 2024; 148(1):11-15. PubMed ID: 37257429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors and 6-month overall outcome of acute kidney injury in Chinese patients receiving PD-1 inhibitors.
    Qin Z; Liu K; Xu X; Li T; Ge Y; Wu B; Xing C; Mao H
    Future Oncol; 2022 May; 18(16):1951-1962. PubMed ID: 35232231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury Induced by Immune Checkpoint Inhibitors in Lung Cancer Patients.
    Lv D; He L; Guo L; Zhang X; He X
    Discov Med; 2022; 33(170):137-141. PubMed ID: 36274242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onco-Nephrology: Kidney Disease in the Cancer Patient.
    Yarandi N; Shirali AC
    Med Clin North Am; 2023 Jul; 107(4):749-762. PubMed ID: 37258012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.